Endovia Health Sciences, Inc. (EDVA) stock

EDVANYSEBeveragesFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30

$0.18+0.02 (+13.45%)

Close on Nov 13, 2026Market cap $137.15KP/E –Yield –

Endovia Health Sciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Endovia Health Sciences's price to sales ratio was 0.9× on Jan 30, 2026, against 1.7× a year earlier. Over the last 5 years it ranged from 0.5× to 100.5×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Jan 30, 2026	0.9×	+0.1
2025	Dec 31, 2025	0.8×	−0.3
2024	Dec 31, 2024	1.1×	−0.2
2023	Dec 29, 2023	1.3×	−1.0
2022	Dec 30, 2022	2.3×	−1.8
2021	Dec 31, 2021	4.1×	−93.1
2020	Dec 31, 2020	97.2×	−54.1
2019	Dec 31, 2019	151.2×	–

Where these numbers come from

Parsed from the XBRL in Endovia Health Sciences's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Jul 27, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing